|
|
|
RESEARCH PAPERS
28. Maruf AA & Bousman CA. (2022). Approaches and Hurdles of Implementing Pharmacogenetic Testing in a Psychiatry Clinic. Psychiatry and Clinical Neurosciences Reports (Submitted).
27. Jessel CD, Maruf AA, Oomen A, Arnold PD & Bousman CA. (2021). Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada. The Journal of the Canadian Academy of Child and Adolescent Psychiatry. 31(1):18-27. PubMed ID: 35251193.
26. Stein K, Maruf AA, Müller DJ, Bishop JR, Bousman CA. (2021). Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 11(12), 1334. PubMed ID: 34945806.
25. Maruf, AA*; Poweleit, EAB*; Brown, LC; Strawn, JR; Bousman, CA. (2021). Systematic Review and Meta-Analysis of L-methylfolate Augmentation in Depressive Disorders. Pharmacospychiatry, Nov 18. doi: 10.1055/a-1681-2047. *Co-first author. [Corresponding Author]. PubMed ID: 34794190.
Pre-University of Manitoba:
24. Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. 31(1):33-45. PubMed ID: 33074724.
23. Liu C, Maruf AA & Bousman C. (2020). Reporting of Clozapine-Induced Gastrointestinal Hypomotility and Factors Associated with Fatal Outcomes in Canada. Psychiatry Research. 290:113048. PubMed ID: 32474068.
22. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Reply to Dawes and Colleagues. Canadian Journal of Psychiatry. PubMed ID: 32425056.
21. Maruf AA, Fan M, Arnold P, Müller DJ, Aitchison K & Bousman C. (2020). Review of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Canadian Journal of Psychiatry. Feb 17:706743720904820. PubMed ID: 32064906.
20. Maruf AA*, Greenslade A*, Arnold PD & Bousman C. (2019). Antidepressant Pharmacogenetics in Children and Adolescent: A Systematic Review. Journal of Affective Disorder. 254:98-108. *Co-first author. PubMed ID: 31112844.
19. Bousman CA, Maruf AA & Müller DJ. (2019). Towards The Integration of Pharmacogenetics in Psychiatry: A Minimum, Evidence-Based Genetic Testing Panel. Current Opinion in Psychiatry, 32(1):7-15. PubMed ID: 30299306.
18. Maruf AA, O’Brien PJ, Naserzadeh P, Fathian R, Salimi A & Pourahmad J. (2018). Methotrexate Induced Mitochondrial Injury and Cytochrome C Release in Rat Liver Hepatocytes. Drug and Chemical Toxicology, 16:1-11. Pubmed ID: 28298149.
17. Zhang T, Mu Y, Yang M, Maruf AA, Li Pi, Li C, Dai S, Lu J & Dong Q. (2017). (+)-Catechin Prevents Methylglyoxal-Induced Mitochondrial Dysfunction and Apoptosis in EA.hy926 Cells. Archives Of Physiology and Biochemistry, 22:1-7. PubMed ID: 28005432.
16. Maruf AA, Lip H, Wong H & O’Brien PJ. (2015). Protective Effects of Ferulic Acid and Related Polyphenols against Glyoxal- or Methylglyoxal-Induced Cytotoxicity and Oxidative Stress in Isolated Rat Hepatocytes. Chemico-Biological Interactions, 234:96-104. PubMed ID: 255446858.
15. Ng CS, Hasnat A, Maruf AA, Ahmed MU, Pirmohamed M, Day CP, Aithal GP & Daly AK. (2014). N-acetyltransferase 2 (NAT2) Genotype as a Risk Factor for Development of Drug-Induced Liver Injury Relating to Antituberculosis Drug Treatment in a Mixed-Ethnicity Patient Group. European Journal of Clinical Pharmacology, 70(9):1079-86. PubMed ID: 24888881.
14. Maruf AA & O’Brien PJ. (2014). Flutamide-Induced Cytotoxicity and Oxidative Stress in an In Vitro Rat Hepatocyte System. Oxidative Medicine and Cellular Longevity, Vol. 2014, Article ID 398285. PubMed ID: 25371773.
13. Maruf AA, Wan L & O’Brien PJ. (2014). Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System. BioMed Research International, Vol. 2014, Article ID 379748. PubMed ID: 25101277.
12. McAllister SL*, Maruf AA*, Wan L, Chung E & O’Brien PJ. (2013). Modeling Xenobiotic Susceptibility to Hepatotoxicity Using an In Vitro Oxidative Stress Inflammation Model. Canadian Journal of Physiology and Pharmacology, 91(3):236-40. *Co-first author. PubMed ID: 23537437.
11. Hassan R, Ameena SS, Maruf AA, Nandini A, Tabin H, Ahmed MU, Islam MS, Sayeed MSB & Hasnat A. (2013). Genotype-Phenotype Variability in Human CYP3A Locus in Nepalese People Residing in Bangladesh. International Journal of Clinical Pharmacology and Therapeutics, 51(3):207-14. PubMed ID: 23320986.
10. Islam MS, Ahmed MU, Bin Sayeed MS, Maruf AA, Mostofa AGM, Hussain SMA, Kabir Y, Daly AK & Hasnat A. (2012). Lung Cancer Risk in Relation to Nicotinic Acetylcholine Receptor, CYP2A6 and CYP1A1 Genotype in Bangladeshi Population. Clinica Chimica Acta, 416:11-9. PubMed ID: 23178447.
9. Maruf AA, Ahmed MU, Azad MAK, Ahmed M & Hasnat A. (2012). CYP3A Genotypes in Bangladeshi Tuberculosis Patients. Bangladesh Medical Research Council Bulletin, 38(1):1-5. PubMed ID: 22545342.
8. Maruf AA, Ahmed MU, Yasmin H, Ullah MA, Azad MAK, Daly AK & Hasnat A. (2011). Genotypes and Phenotypes of CYP3A in Bangladeshi Population. Clinica Chimica Acta, 412(7-8): 531-536. PubMed ID: 21114969.
7. Mannan SJ, Azad MA, Ullah M, Maruf AA, Rayhan I, Ahsan MS & Hasnat A. (2011). Investigation of Serum Trace Element, Malondialdehyde and Immune Status in Drug Abuser Patients Undergoing Detoxification. Biological Trace Element Research, 140(3):272-83. PubMed ID: 20390377.
6. Islam MS, Trini AB, Shohag MH, Ahmed MU, Maruf AA & Hasnat A. (2011). Comparative Bioavailability Study of Omeprazole 20 mg Capsule Encapsulated with Omeprazole 22.5% Enteric Coated Pellets with Reference Product in Healthy Bangladeshi Male Subjects: An Open-Label, Single-Dose, Randomized-Sequence, Two-Way Crossover Study. International Journal of Clinical Pharmacology and Therapeutics, 49(12):778-86. PubMed ID: 22122821.
5. Chowdhury MM, Ullah MA, Iqbal N, Maruf AA, Shohag MH, Harun S, Akter KA, Begum B, Latif AHMM & Hasnat A. (2011). Relative Bioavailability and Pharmacokinetic Study of Two Trimetazidine Modified Release Formulations in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(7):393-8. PubMed ID: 21899207.
4. Sultana TA, Islam MS, Bhuiyan MHU, Shohag MH, Ahmed MU, Naznin SR, Maruf AA, Huq SM & Hasnat A. (2011). Comparative Pharmacokinetic and Relative Bioavailability Study of Coated and Uncoated Azithromycin Powder for Suspension in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(10):594-8. PubMed ID: 22164968.
3. Shahed GM, Ullah MA, Maruf AA, Ahmed MU, Islam MS, Nahar Z & Hasnat A. (2011). A Simple RP−HPLC Method for the Determination of Cefdinir in Human Serum: Validation and Application in a Pharmacokinetic Study with healthy Bangladeshi Male Volunteers. Dhaka University Journal of Pharmaceutical Sciences, 10(2):109-116. View.
2. Ullah MA, Dowla SU, Maruf AA, Sultana R, Azad MAK, Shohag MD, Latif AHMM & Hasnat A. (2010). Pharmacokinetics, 2. Bioequivalence and Tolerability Study of Two Different Enteric Formulations of Esomeprazole in Healthy Bangladeshi Male Volunteers: An Open Label, Single-Dose, Randomized, Two-Way Crossover Study. Clinical Therapeutics, 32(7):1419-1426. PubMed ID: 20678688.
1. Haider N, Islam MS, Maruf AA, Shohag MH, Ali R, Rahman GKMM & Hasnat A. (2010). Oxidative Stress and Antioxidant Status in Vitiligo Patients. Dhaka University Journal of Pharmaceutical Sciences, 9(2):103-108. View.
BOOK CHAPTERS:
3. Maruf AA & Bousman C. (2020). Towards Multi-Omic Informed Psychotropic Prescribing. In. Convergence Mental Health: A Roadmap Towards Transdisciplinary Innovation and Entrepreneurship. Eyre, Reynolds III, Berk, Lavretsky, Editors. Oxford University Press, United Kingdom. ISBN: 978-0-19-750627-1.
2. Maruf AA & O’Brien PJ. (2015). Pharmaceutical Agents. In: Studies on Experimental Toxicology & Pharmacology. Roberts SM, Kehrer JP, Klotz L-O, Editors. Vol-1, Humana Press (Springer), Switzerland. ISBN: 978-3-319-19096-9.
1. Maruf AA, Lee W & O’Brien PJ. (2014). Modifications of Mitochondrial Function by Toxicants. In: Reference Module in Biomedical Sciences. Caplan MJ, Editor. Elsevier B.V., Netherlands. ISBN: 978-0-12-801238-3.
CONFERENCES:
17. Maruf AA, Peroramas K & Arnold PD, Aitchison K, Müller DJ & Bousman C. (2021).Pharmacogenetics of Obsessive-Compulsive Disorder: A Systematic Review. 41st Annual Canadian Academy of Child and Adolescent Psychiatry Virtual Conference, Virtual, Sep 11-14 [Poster].
Pre-University of Manitoba:
16. Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). A Systematic Review of CYP2D6 Genetic Variants and Antipsychotic Treatment Outcomes in Children and Youth. 2020 Virtual World Congress of Psychiatric Genetics, Virtual, Oct 19-22 [Poster].
15. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Considerations in Assessing Pharmacogenetic Tests Relevant to Psychiatry in Canada. 40th Annual Canadian Academy of Child and Adolescent Psychiatry Conference, Virtual, Sep 12-15. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 29(4): Suppl 38. [Poster].
14. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Identification and Evaluation of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Pharmacogenomics Conference 2020 - University of Minnesota, Virtual, Sep 11-12 [Poster].
13. Maruf AA, Greenslade A, Arnold PD & Bousman C. (2019). A Systematic Review of Antidepressant Pharmacogenetics in Children and Young Adults. 2019 World Congress on Psychiatric Genetics, Anaheim, CA, USA, Oct 26-31. European Neuropsychopharmacology, 29(5): S151 [Poster].
12. Maruf AA & O’Brien PJ. (2014). Effects of Inflammation on Nilutamide-Induced Liver Injury. 35th Annual Meeting of the American College of Toxicology, Orlando, Florida, USA, Nov 9-12 [Poster]. [Travel Award Winner]
11. Maruf AA & O’Brien PJ. (2014). Inflammation-Enhanced Drug-Induced Liver Injury. The Society for Free Radical Research-Europe Meeting, Paris, France, Sep 5-7. Free Radical Biology and Medicine, 75(Suppl 1): S40 [Poster].
10. Maruf AA, Lip H, Li R & O’Brien PJ. (2014). Protective Effects of Ferulic Acid and Related Ferulic Acid Derivatives against Glyoxal- or Methyl Glyoxal-Induced Protein Carbonylation and Oxidative Stress. The 17th International Workshop on the Enzymology and Molecular Biology of Carbonyl Metabolism, Pennsylvania, USA, July 8-13 [Oral & Poster]. [Trainee Award Winner]
9. Maruf AA & O’Brien PJ. (2014). Evaluation of Flutamide-Induced Hepatotoxicity in an In Vitro Oxidative Stress-Inflammation Model. 8th Meeting of the Canadian Oxidative Stress Consortium, Carleton University, Ottawa, Canada, June 11-13 [Poster].
8. Maruf AA & O’Brien PJ. (2014). Accelerated Cytotoxicity Mechanism Screening of Flutamide in Isolated Rat Hepatocytes. 53rd Annual Meeting of the Society of Toxicology, Phoenix, Arizona, USA, March 23-27. The Toxicologist, 2014:493 [Poster]. [Travel Award Winner] [Pharmacology Book Fund Winner]
7. Maruf AA & O’Brien PJ. (2013). Potential Molecular Cytotoxic Mechanisms of Methotrexate in Isolated Rat Hepatocytes. 10th International Society for the Study of Xenobiotics Meeting, Toronto, Ontario, Canada, Sep 29-Oct 3. Drug Metabolism Reviews, 45(S1):176 [Poster].
6. Maruf AA, Arvadia P, Michail K, Khan SR, Siraki AG & O’Brien PJ. (2013). Effects of Inflammation on 6-Mercaptopurine Induced Cytotoxicity towards Freshly Isolated Rat Hepatocytes. 20th Annual Meeting Society for Free Radical Biology and Medicine, San Antonio, Texas, USA, November 20-24. Free Radical Biology and Medicine, 65(Suppl 2):S37 [Poster]. [SGS Conference Grant Winner]
5. Maruf AA & O’Brien PJ. (2013). Azathioprine-Induced Hepatotoxicity in an In Vitro Inflammation-Immune Model. 52nd Annual Meeting of the Society of Toxicology, San Antonio, Texas, USA, March 10-14. The Toxicologist, 2013:512 [Poster].
4. Maruf AA & O’Brien PJ. (2012). Accelerated Cytotoxicity Mechanism Screening of Methotrexate Using an In Vitro Hepatocyte Inflammation-Immune Model. 35th Annual Meeting of the American College of Toxicology, Orlando, Florida, USA, Nov 4-7 [Poster]. [Travel Award Winner]
3. Maruf AA, Ahmed M, Azad MAK, Ahmed M & Hasnat A. (2011). CYP3A Genotypes in Bangladeshi Tuberculosis Patients. HUGO’s 15th Human Genome Meeting and 4th Pan Arab Human Genetics Conference: Genomics of Human Diversity and Heritable Disorders, Dubai, UAE, March 14-17. The HUGO Journal, 5(Suppl 1):251-252 [Poster].
2. Maruf AA, Ahmed M, Azad MAK, Ullah MA & Hasnat A. (2010). Pharmacogenetics of CYP3A4 in Bangladeshi population including TB patients. HUGO’s 14th Human Genome Meeting: Next Generation Genomics and Medicine, Montpellier, France, May 18-21. The HUGO Journal, 4(Suppl 1):107-108 [Oral and Poster]. [Young Scientist Travel Award Winner]
1. Maruf AA, Ahmed MU & Hasnat A. (2009). Genotypes and Phenotypes of CYP3A4 in Bangladeshi People. 1st Young Scientists Congress of the Academy of Sciences, Dhaka, Bangladesh, December 30, pp. 48 [Oral].
28. Maruf AA & Bousman CA. (2022). Approaches and Hurdles of Implementing Pharmacogenetic Testing in a Psychiatry Clinic. Psychiatry and Clinical Neurosciences Reports (Submitted).
27. Jessel CD, Maruf AA, Oomen A, Arnold PD & Bousman CA. (2021). Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada. The Journal of the Canadian Academy of Child and Adolescent Psychiatry. 31(1):18-27. PubMed ID: 35251193.
26. Stein K, Maruf AA, Müller DJ, Bishop JR, Bousman CA. (2021). Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 11(12), 1334. PubMed ID: 34945806.
25. Maruf, AA*; Poweleit, EAB*; Brown, LC; Strawn, JR; Bousman, CA. (2021). Systematic Review and Meta-Analysis of L-methylfolate Augmentation in Depressive Disorders. Pharmacospychiatry, Nov 18. doi: 10.1055/a-1681-2047. *Co-first author. [Corresponding Author]. PubMed ID: 34794190.
Pre-University of Manitoba:
24. Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. 31(1):33-45. PubMed ID: 33074724.
23. Liu C, Maruf AA & Bousman C. (2020). Reporting of Clozapine-Induced Gastrointestinal Hypomotility and Factors Associated with Fatal Outcomes in Canada. Psychiatry Research. 290:113048. PubMed ID: 32474068.
22. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Reply to Dawes and Colleagues. Canadian Journal of Psychiatry. PubMed ID: 32425056.
21. Maruf AA, Fan M, Arnold P, Müller DJ, Aitchison K & Bousman C. (2020). Review of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Canadian Journal of Psychiatry. Feb 17:706743720904820. PubMed ID: 32064906.
20. Maruf AA*, Greenslade A*, Arnold PD & Bousman C. (2019). Antidepressant Pharmacogenetics in Children and Adolescent: A Systematic Review. Journal of Affective Disorder. 254:98-108. *Co-first author. PubMed ID: 31112844.
19. Bousman CA, Maruf AA & Müller DJ. (2019). Towards The Integration of Pharmacogenetics in Psychiatry: A Minimum, Evidence-Based Genetic Testing Panel. Current Opinion in Psychiatry, 32(1):7-15. PubMed ID: 30299306.
18. Maruf AA, O’Brien PJ, Naserzadeh P, Fathian R, Salimi A & Pourahmad J. (2018). Methotrexate Induced Mitochondrial Injury and Cytochrome C Release in Rat Liver Hepatocytes. Drug and Chemical Toxicology, 16:1-11. Pubmed ID: 28298149.
17. Zhang T, Mu Y, Yang M, Maruf AA, Li Pi, Li C, Dai S, Lu J & Dong Q. (2017). (+)-Catechin Prevents Methylglyoxal-Induced Mitochondrial Dysfunction and Apoptosis in EA.hy926 Cells. Archives Of Physiology and Biochemistry, 22:1-7. PubMed ID: 28005432.
16. Maruf AA, Lip H, Wong H & O’Brien PJ. (2015). Protective Effects of Ferulic Acid and Related Polyphenols against Glyoxal- or Methylglyoxal-Induced Cytotoxicity and Oxidative Stress in Isolated Rat Hepatocytes. Chemico-Biological Interactions, 234:96-104. PubMed ID: 255446858.
15. Ng CS, Hasnat A, Maruf AA, Ahmed MU, Pirmohamed M, Day CP, Aithal GP & Daly AK. (2014). N-acetyltransferase 2 (NAT2) Genotype as a Risk Factor for Development of Drug-Induced Liver Injury Relating to Antituberculosis Drug Treatment in a Mixed-Ethnicity Patient Group. European Journal of Clinical Pharmacology, 70(9):1079-86. PubMed ID: 24888881.
14. Maruf AA & O’Brien PJ. (2014). Flutamide-Induced Cytotoxicity and Oxidative Stress in an In Vitro Rat Hepatocyte System. Oxidative Medicine and Cellular Longevity, Vol. 2014, Article ID 398285. PubMed ID: 25371773.
13. Maruf AA, Wan L & O’Brien PJ. (2014). Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System. BioMed Research International, Vol. 2014, Article ID 379748. PubMed ID: 25101277.
12. McAllister SL*, Maruf AA*, Wan L, Chung E & O’Brien PJ. (2013). Modeling Xenobiotic Susceptibility to Hepatotoxicity Using an In Vitro Oxidative Stress Inflammation Model. Canadian Journal of Physiology and Pharmacology, 91(3):236-40. *Co-first author. PubMed ID: 23537437.
11. Hassan R, Ameena SS, Maruf AA, Nandini A, Tabin H, Ahmed MU, Islam MS, Sayeed MSB & Hasnat A. (2013). Genotype-Phenotype Variability in Human CYP3A Locus in Nepalese People Residing in Bangladesh. International Journal of Clinical Pharmacology and Therapeutics, 51(3):207-14. PubMed ID: 23320986.
10. Islam MS, Ahmed MU, Bin Sayeed MS, Maruf AA, Mostofa AGM, Hussain SMA, Kabir Y, Daly AK & Hasnat A. (2012). Lung Cancer Risk in Relation to Nicotinic Acetylcholine Receptor, CYP2A6 and CYP1A1 Genotype in Bangladeshi Population. Clinica Chimica Acta, 416:11-9. PubMed ID: 23178447.
9. Maruf AA, Ahmed MU, Azad MAK, Ahmed M & Hasnat A. (2012). CYP3A Genotypes in Bangladeshi Tuberculosis Patients. Bangladesh Medical Research Council Bulletin, 38(1):1-5. PubMed ID: 22545342.
8. Maruf AA, Ahmed MU, Yasmin H, Ullah MA, Azad MAK, Daly AK & Hasnat A. (2011). Genotypes and Phenotypes of CYP3A in Bangladeshi Population. Clinica Chimica Acta, 412(7-8): 531-536. PubMed ID: 21114969.
7. Mannan SJ, Azad MA, Ullah M, Maruf AA, Rayhan I, Ahsan MS & Hasnat A. (2011). Investigation of Serum Trace Element, Malondialdehyde and Immune Status in Drug Abuser Patients Undergoing Detoxification. Biological Trace Element Research, 140(3):272-83. PubMed ID: 20390377.
6. Islam MS, Trini AB, Shohag MH, Ahmed MU, Maruf AA & Hasnat A. (2011). Comparative Bioavailability Study of Omeprazole 20 mg Capsule Encapsulated with Omeprazole 22.5% Enteric Coated Pellets with Reference Product in Healthy Bangladeshi Male Subjects: An Open-Label, Single-Dose, Randomized-Sequence, Two-Way Crossover Study. International Journal of Clinical Pharmacology and Therapeutics, 49(12):778-86. PubMed ID: 22122821.
5. Chowdhury MM, Ullah MA, Iqbal N, Maruf AA, Shohag MH, Harun S, Akter KA, Begum B, Latif AHMM & Hasnat A. (2011). Relative Bioavailability and Pharmacokinetic Study of Two Trimetazidine Modified Release Formulations in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(7):393-8. PubMed ID: 21899207.
4. Sultana TA, Islam MS, Bhuiyan MHU, Shohag MH, Ahmed MU, Naznin SR, Maruf AA, Huq SM & Hasnat A. (2011). Comparative Pharmacokinetic and Relative Bioavailability Study of Coated and Uncoated Azithromycin Powder for Suspension in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(10):594-8. PubMed ID: 22164968.
3. Shahed GM, Ullah MA, Maruf AA, Ahmed MU, Islam MS, Nahar Z & Hasnat A. (2011). A Simple RP−HPLC Method for the Determination of Cefdinir in Human Serum: Validation and Application in a Pharmacokinetic Study with healthy Bangladeshi Male Volunteers. Dhaka University Journal of Pharmaceutical Sciences, 10(2):109-116. View.
2. Ullah MA, Dowla SU, Maruf AA, Sultana R, Azad MAK, Shohag MD, Latif AHMM & Hasnat A. (2010). Pharmacokinetics, 2. Bioequivalence and Tolerability Study of Two Different Enteric Formulations of Esomeprazole in Healthy Bangladeshi Male Volunteers: An Open Label, Single-Dose, Randomized, Two-Way Crossover Study. Clinical Therapeutics, 32(7):1419-1426. PubMed ID: 20678688.
1. Haider N, Islam MS, Maruf AA, Shohag MH, Ali R, Rahman GKMM & Hasnat A. (2010). Oxidative Stress and Antioxidant Status in Vitiligo Patients. Dhaka University Journal of Pharmaceutical Sciences, 9(2):103-108. View.
BOOK CHAPTERS:
3. Maruf AA & Bousman C. (2020). Towards Multi-Omic Informed Psychotropic Prescribing. In. Convergence Mental Health: A Roadmap Towards Transdisciplinary Innovation and Entrepreneurship. Eyre, Reynolds III, Berk, Lavretsky, Editors. Oxford University Press, United Kingdom. ISBN: 978-0-19-750627-1.
2. Maruf AA & O’Brien PJ. (2015). Pharmaceutical Agents. In: Studies on Experimental Toxicology & Pharmacology. Roberts SM, Kehrer JP, Klotz L-O, Editors. Vol-1, Humana Press (Springer), Switzerland. ISBN: 978-3-319-19096-9.
1. Maruf AA, Lee W & O’Brien PJ. (2014). Modifications of Mitochondrial Function by Toxicants. In: Reference Module in Biomedical Sciences. Caplan MJ, Editor. Elsevier B.V., Netherlands. ISBN: 978-0-12-801238-3.
CONFERENCES:
17. Maruf AA, Peroramas K & Arnold PD, Aitchison K, Müller DJ & Bousman C. (2021).Pharmacogenetics of Obsessive-Compulsive Disorder: A Systematic Review. 41st Annual Canadian Academy of Child and Adolescent Psychiatry Virtual Conference, Virtual, Sep 11-14 [Poster].
Pre-University of Manitoba:
16. Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). A Systematic Review of CYP2D6 Genetic Variants and Antipsychotic Treatment Outcomes in Children and Youth. 2020 Virtual World Congress of Psychiatric Genetics, Virtual, Oct 19-22 [Poster].
15. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Considerations in Assessing Pharmacogenetic Tests Relevant to Psychiatry in Canada. 40th Annual Canadian Academy of Child and Adolescent Psychiatry Conference, Virtual, Sep 12-15. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 29(4): Suppl 38. [Poster].
14. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Identification and Evaluation of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Pharmacogenomics Conference 2020 - University of Minnesota, Virtual, Sep 11-12 [Poster].
13. Maruf AA, Greenslade A, Arnold PD & Bousman C. (2019). A Systematic Review of Antidepressant Pharmacogenetics in Children and Young Adults. 2019 World Congress on Psychiatric Genetics, Anaheim, CA, USA, Oct 26-31. European Neuropsychopharmacology, 29(5): S151 [Poster].
12. Maruf AA & O’Brien PJ. (2014). Effects of Inflammation on Nilutamide-Induced Liver Injury. 35th Annual Meeting of the American College of Toxicology, Orlando, Florida, USA, Nov 9-12 [Poster]. [Travel Award Winner]
11. Maruf AA & O’Brien PJ. (2014). Inflammation-Enhanced Drug-Induced Liver Injury. The Society for Free Radical Research-Europe Meeting, Paris, France, Sep 5-7. Free Radical Biology and Medicine, 75(Suppl 1): S40 [Poster].
10. Maruf AA, Lip H, Li R & O’Brien PJ. (2014). Protective Effects of Ferulic Acid and Related Ferulic Acid Derivatives against Glyoxal- or Methyl Glyoxal-Induced Protein Carbonylation and Oxidative Stress. The 17th International Workshop on the Enzymology and Molecular Biology of Carbonyl Metabolism, Pennsylvania, USA, July 8-13 [Oral & Poster]. [Trainee Award Winner]
9. Maruf AA & O’Brien PJ. (2014). Evaluation of Flutamide-Induced Hepatotoxicity in an In Vitro Oxidative Stress-Inflammation Model. 8th Meeting of the Canadian Oxidative Stress Consortium, Carleton University, Ottawa, Canada, June 11-13 [Poster].
8. Maruf AA & O’Brien PJ. (2014). Accelerated Cytotoxicity Mechanism Screening of Flutamide in Isolated Rat Hepatocytes. 53rd Annual Meeting of the Society of Toxicology, Phoenix, Arizona, USA, March 23-27. The Toxicologist, 2014:493 [Poster]. [Travel Award Winner] [Pharmacology Book Fund Winner]
7. Maruf AA & O’Brien PJ. (2013). Potential Molecular Cytotoxic Mechanisms of Methotrexate in Isolated Rat Hepatocytes. 10th International Society for the Study of Xenobiotics Meeting, Toronto, Ontario, Canada, Sep 29-Oct 3. Drug Metabolism Reviews, 45(S1):176 [Poster].
6. Maruf AA, Arvadia P, Michail K, Khan SR, Siraki AG & O’Brien PJ. (2013). Effects of Inflammation on 6-Mercaptopurine Induced Cytotoxicity towards Freshly Isolated Rat Hepatocytes. 20th Annual Meeting Society for Free Radical Biology and Medicine, San Antonio, Texas, USA, November 20-24. Free Radical Biology and Medicine, 65(Suppl 2):S37 [Poster]. [SGS Conference Grant Winner]
5. Maruf AA & O’Brien PJ. (2013). Azathioprine-Induced Hepatotoxicity in an In Vitro Inflammation-Immune Model. 52nd Annual Meeting of the Society of Toxicology, San Antonio, Texas, USA, March 10-14. The Toxicologist, 2013:512 [Poster].
4. Maruf AA & O’Brien PJ. (2012). Accelerated Cytotoxicity Mechanism Screening of Methotrexate Using an In Vitro Hepatocyte Inflammation-Immune Model. 35th Annual Meeting of the American College of Toxicology, Orlando, Florida, USA, Nov 4-7 [Poster]. [Travel Award Winner]
3. Maruf AA, Ahmed M, Azad MAK, Ahmed M & Hasnat A. (2011). CYP3A Genotypes in Bangladeshi Tuberculosis Patients. HUGO’s 15th Human Genome Meeting and 4th Pan Arab Human Genetics Conference: Genomics of Human Diversity and Heritable Disorders, Dubai, UAE, March 14-17. The HUGO Journal, 5(Suppl 1):251-252 [Poster].
2. Maruf AA, Ahmed M, Azad MAK, Ullah MA & Hasnat A. (2010). Pharmacogenetics of CYP3A4 in Bangladeshi population including TB patients. HUGO’s 14th Human Genome Meeting: Next Generation Genomics and Medicine, Montpellier, France, May 18-21. The HUGO Journal, 4(Suppl 1):107-108 [Oral and Poster]. [Young Scientist Travel Award Winner]
1. Maruf AA, Ahmed MU & Hasnat A. (2009). Genotypes and Phenotypes of CYP3A4 in Bangladeshi People. 1st Young Scientists Congress of the Academy of Sciences, Dhaka, Bangladesh, December 30, pp. 48 [Oral].